Payment processor for telemed hormone therapy

Telemedicine hormone clinics (testosterone replacement, hormone replacement, peptide therapy, GLP-1 prescribers, anti-aging, wellness compounding) live in a narrow lane between approved telehealth and restricted pharma. Who approves, who declines, and what compliance posture you need to get underwritten — here is the 2026 honest state.

1. Category classification — why it matters

Your business falls into one of several underwriting buckets, and the bucket determines the processor lineup:

• Generic telemedicine (urgent care, dermatology, behavioral health): mainstream processors OK if you are licensed and compliant.
• TRT / HRT clinics: high-risk. Most payfacs decline or impose tight limits.
• GLP-1 telehealth (semaglutide, tirzepatide compounded): high-risk, additional scrutiny due to FDA compounding-pharmacy rules.
• Peptide therapy clinics: very high-risk, borderline between telemedicine and peptide category.
• Wellness / anti-aging / "IV therapy" clinics: medium-risk, depends on service mix.

2. Who declines telemed hormone clinics

• Stripe — the Stripe Telehealth program approves general telehealth but typically declines TRT, HRT, peptide, and compounded GLP-1 under the "unapproved pharmaceuticals" clause.
• Square — declines hormone-specific telemed after SKU review.
• PayPal — declines.
• Shopify Payments — Stripe underneath, same outcome.

3. Who approves telemed hormone clinics

Corepay (Authorize.net)

• Rate: 3.8-4.8% effective.
• Reserve: 10-15% rolling, 180 days.
• Strength: active telehealth book, underwriting team familiar with hormone clinics.
• Requirements: medical license documentation, compounding pharmacy relationships documented, HIPAA compliance attestation.

PayKings (Authorize.net / NMI)

• Rate: 4.0-5.0% effective.
• Reserve: 10-15% rolling, 180 days.
• Strength: broader high-risk book including hormone/peptide telemed.

EasyPayDirect (selective)

• Rate: 3.8-4.7% effective.
• Reserve: 10-15% rolling, 180 days.
• Caveat: approves general TRT/HRT; GLP-1 and peptide therapy case-by-case.

Specialty telehealth desks

A handful of ISOs market specifically to telehealth operators. Rates similar to above; diligence on track record before signing.

4. Compliance prerequisites for approval

Medical licensing

• Licensed medical director in every state where you operate.
• State-by-state prescribing authority documentation.
• DEA registration where required for controlled substances.

Pharmacy relationships

• Named compounding pharmacy (503A or 503B) with valid state licenses.
• Distribution agreement documented.
• Chain-of-custody documentation for controlled and compounded substances.

HIPAA compliance

• HIPAA BAA with every vendor touching PHI.
• Encrypted data at rest and in transit.
• Access controls and audit logging.
• Patient portal with appropriate authentication.

Clinical workflow

• Licensed-provider-authored intake flow.
• Asynchronous or synchronous consult documented per visit.
• Lab work prior to prescription (testosterone panel, thyroid, lipid, etc.).
• Follow-up cadence aligned with scope of practice.

Marketing discipline

• No therapeutic claims beyond approved indications.
• Clear disclosure that patient evaluation is required before prescription.
• No direct-to-consumer advertising of Schedule III+ substances in restrictive states.

5. Chargeback prevention (hormone clinic specific)

Telemed hormone chargeback drivers:

• Patients disputing subscription renewals after discontinuing treatment.
• Descriptor confusion ("I didn't recognize this charge").
• Side-effect complaints routed through card issuer instead of clinic.
• Lab or medication delivery delays.

Defense: clear descriptor matching brand, auto-email order confirmations, generous cancellation policy, responsive customer service, Ethoca + Verifi alerts.

6. Subscription architecture

Telemed hormone is subscription-heavy. Work with a subscription engine that supports your gateway:

• Recharge — supports Authorize.net, NMI, some direct gateways.
• Chargebee — broader gateway support, better for complex billing.
• Custom billing engine — possible, more engineering overhead.

Your subscription engine must handle: dose titrations (billing changes mid-cycle), paused subscriptions during lab-wait windows, and HIPAA-compliant handling of clinical triggers.

7. Multi-clinic / multi-brand operators

If you run multiple telehealth brands (TRT clinic + HRT clinic + GLP-1 clinic + wellness clinic) under one parent medical group, a parent MID with orchestrated sub-brand descriptors usually wins:

• One underwriting relationship (versus N).
• Consolidated HIPAA compliance posture.
• One chargeback queue.
• Portfolio-level rate leverage.

Concentration risk applies — if one brand triggers regulatory attention, all brands are exposed. Balance carefully. Apply for a sizing.

8. Rate and reserve reality

• Domestic telemed hormone rate: 3.8-5.0% effective.
• Reserve: 10-15% rolling, 180 days typical.
• Volume caps: $100-500k/mo on new accounts, lifting after 90-180 days of clean processing.

9. What NOT to do

• Do not apply to Stripe claiming you are "general telehealth" if you are selling hormone or peptide therapy. The SKU review will catch the specific substances and close the account.
• Do not process controlled substances without DEA registration. This goes beyond processor risk.
• Do not use consumer-grade Zoom for HIPAA-sensitive consults. Use a HIPAA-compliant telehealth platform.
• Do not let marketing outrun clinical protocols. FTC and state AG actions against telemed clinics are accelerating in 2026.

10. Our honest recommendation

• Single clinic, under $150k/mo, general TRT/HRT: apply to Corepay and EasyPayDirect in parallel. Plan 10-14 days underwriting.
• GLP-1 focused clinic: expect tighter underwriting, higher reserves. Plan for 4-5% effective rate.
• Peptide therapy clinic: closest to pure-peptide underwriting. Use the peptide processor guide.
• Multi-clinic operator: parent MID consolidation usually wins above $300k/mo portfolio volume.

Next step

Apply in 12 questions for an honest fit analysis sized to your clinic architecture.